ATP citrate lyase
ACLY (ATP citrate lyase) catalyzes the synthesis of acetyl-CoA from citrate. It is a cytosolic enzyme that involved in fetal growth/development, tumor cell growth/survival and metabolic disorder etc.
Products for ATP citrate lyase
- Cat.No. Product Name Information
- GC48923 (±)-Hydroxycitric Acid A hydroxy derivative of citric acid
- GC63570 (-)-Hydroxycitric acid lactone (-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent and a popular weight loss food supplement.
- GC31632 2-Furoic acid (Furan-2-carboxylic acid) 2-Furoic acid (Furan-2-carboxylic acid) (Furan-2-carboxylic acid) is an organic compound produced through furfural oxidation.
- GC10884 BMS-303141 ATP-citrate lyase inhibitor,potent
- GC33760 ETC-1002 (ESP-55016) ETC-1002 (ESP-55016) (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor.
- GC60919 Hydroxycitric acid tripotassium hydrate Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) is the major active ingredient of Garcinia cambogia.
- GC38932 NDI-091143 NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay), a Ki of 7.0 nM and a Kd of 2.2 nM. NDI-091143 inhibits ACLY catalysis allosterically, by stabilizing large conformational changes in the citrate domain that indirectly block the binding and recognition of citrate.
- GC16952 SB 204990 ATP citrate lyase (ACLY) inhibitor